INOVIO And GeneOne Life Science To Present Phase 1/2a Clinical Data With DNA Vaccine INO-4700 For MERS Coronavirus At ASGCT Conference; Say Vaccine Demonsrates 100% Binding And 92% Neutralizing Antibody Response
Benzinga Newsdesk